Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.

× No keyword cloud information.

17 in total

Review 1. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors: Michael Camilleri; David A Katzka
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-03-08 Impact factor: 4.052

2. Irritable bowel syndrome: how useful is the term and the 'diagnosis'?

Authors: Michael Camilleri
Journal: Therap Adv Gastroenterol Date: 2012-11 Impact factor: 4.409

Review 3. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.

Authors: Dervla O'Malley
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-10-13 Impact factor: 4.052

Review 4. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract.

Authors: Nigel W Bunnett
Journal: J Physiol Date: 2014-03-10 Impact factor: 5.182

5. Formulary Drug Reviews: Plecanatide.

Authors: Danial E Baker
Journal: Hosp Pharm Date: 2017-07-13

6. Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.

Authors: Kunwar Shailubhai; Stephen Comiskey; John A Foss; Rong Feng; Laura Barrow; Gail M Comer; Gary S Jacob
Journal: Dig Dis Sci Date: 2013-04-27 Impact factor: 3.199

Review 7. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.

Authors: M Camilleri; A Acosta
Journal: Neurogastroenterol Motil Date: 2014-12-29 Impact factor: 3.598

8. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.

Authors: Farzad Alemi; Daniel P Poole; Jonathan Chiu; Kristina Schoonjans; Fiore Cattaruzza; John R Grider; Nigel W Bunnett; Carlos U Corvera
Journal: Gastroenterology Date: 2012-10-03 Impact factor: 22.682

9. Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores.

Authors: Jeffrey M Lackner; James Jaccard; Charles Baum
Journal: Value Health Date: 2012-11-30 Impact factor: 5.725

Review 10. Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.

Authors: Michael Camilleri
Journal: J Clin Invest Date: 2013-10-01 Impact factor: 14.808